<DOC>
	<DOCNO>NCT00680732</DOCNO>
	<brief_summary>Our objective investigate importance malaria infection/disease pregnancy particularly first trimester ; also look maternal-foetal interaction influence subsequent child 's response malaria infection first year life . This study carry ! population recruit IUGR study ( NCT00642408 ) .</brief_summary>
	<brief_title>Prevention Intrauterine Growth Retardation Burkina Faso : Malaria Component</brief_title>
	<detailed_description>A research project aim investigating impact multivitamin-mineral supplementation ( MMS ) pregnancy intra-uterin growth retardation carry Hounde district , area far Centre Muraz locate Bobo Dioulasso , malaria endemic . Malaria pregnancy increase risk low birth weight , infant mortality morbidity first year life induce growth retardation , prematurity infant anaemia . The administration antimalarial drug pregnancy beneficial effect mother child 's health preventing malaria infection consequence . However , study carry second third trimester pregnancy : effect malaria infection first trimester mother 's child 's health unknown . It report even one single infection may significant impact outcome pregnancy : true , early chemoprophylaxis may additional advantage . An alternative approach administration intermittent presumptive treatment , may achieve equal efficacy continuo chemoprophylaxis ; however , study compare effective weekly malaria chemoprophylaxis effective intermittent presumptive treatment . Moreover , incidence malaria clinical episode SP intermittent preventive treatment never investigate . Therefore , open label , factorial study carry woman recruit IUGR nutritional study ( NCT00642408 ) . Women receive multiple micronutrient supplement ( MMS ) dietary supplement ( IFA ) randomise 2 group : CQ weekly chemoprophylaxis SP intermittent preventive treatment . The administration treatment directly observe .</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Fetal Growth Retardation</mesh_term>
	<mesh_term>Iron</mesh_term>
	<mesh_term>Trace Elements</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<mesh_term>Micronutrients</mesh_term>
	<mesh_term>Pyrimethamine</mesh_term>
	<mesh_term>Chloroquine</mesh_term>
	<mesh_term>Chloroquine diphosphate</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<criteria>15 44 year females live study area plan move outside district within two year regularly use contraceptive method already pregnant start trial</criteria>
	<gender>Female</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>44 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>Malaria</keyword>
	<keyword>Pregnancy</keyword>
	<keyword>Prevention</keyword>
	<keyword>Chloroquine</keyword>
	<keyword>Sulphadoxine pyrimethamine</keyword>
	<keyword>Maternal anaemia</keyword>
	<keyword>Birth weight</keyword>
	<keyword>Foetal anaemia</keyword>
</DOC>